Why is Nectar Lifesci. falling/rising?

As of 21-Aug, Nectar Lifescience Ltd's stock price is currently at 15.23, reflecting a decrease of 0.05, or 0.33%. The stock has shown a mixed performance recently, with a 4.60% increase over the past week, but a significant decline of 17.00% over the past month. Today's trading indicates that the stock has underperformed its sector by 0.79%, and while it is higher than its 5-day moving average, it remains below the 20-day, 50-day, 100-day, and 200-day moving averages. The company is facing challenges, including operating losses and a high Debt to EBITDA ratio of 7.73 times, which indicates a low ability to service debt. Additionally, the stock has seen a drastic decline in profitability, with a return on equity averaging only 0.55%. The recent financial results have also been disappointing, with a significant drop in profit before tax and profit after tax compared to previous quarters.
In the broader market context, the stock's short-term return of 4.60% over the past week outperformed the Sensex, which increased by 1.74% during the same period. However, the long-term outlook remains bleak, with the stock down 60.95% year-to-date, contrasting sharply with the Sensex's gain of 4.94%. The high percentage of pledged promoter shares, at 99.6%, adds to the downward pressure on the stock, especially in a declining market. Overall, the combination of weak fundamentals, negative financial results, and poor long-term performance relative to the benchmark has contributed to the stock's recent decline.